benazepril hydrochloride and hydrochlorothiazide (62559-417)

Drug Facts

Product Profile

Brand Name benazepril hydrochloride and hydrochlorothiazide

Generic Name benazepril hydrochloride and hydrochlorothiazide

Labeler ani pharmaceuticals, inc.

Dosage Form TABLET

Routes

ORAL

Active Ingredients

benazepril hydrochloride 20 mg/1, hydrochlorothiazide 25 mg/1

Manufacturer

ANI Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 62559-417

Product ID 62559-417_052493c7-89a3-452e-8140-04dd95f0d9e2

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA076342

Listing Expiration 2026-12-31

Marketing Start 2022-11-07

Pharmacologic Class

Established (EPC)

thiazide diuretic [epc]

Chemical Structure

thiazides [cs]

Physiologic Effect

increased diuresis [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62559417

Hyphenated Format 62559-417

Supplemental Identifiers

RxCUI

898362 898367 898372 898378

UPC

0362559415019 0362559416016 0362559414012 0362559417013

UNII

0J48LPH2TH N1SN99T69T

NUI

N0000175359 N0000175419 M0471776

Packaging Origin

Original Packager

true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name benazepril hydrochloride and hydrochlorothiazide (source: ndc)

Generic Name benazepril hydrochloride and hydrochlorothiazide (source: ndc)

Application Number ANDA076342 (source: ndc)

Routes

ORAL

source: ndc

Resolved Composition

Strengths

20 mg/1
25 mg/1

source: ndc

Packaging

100 TABLET in 1 BOTTLE (62559-417-01)

source: ndc

Packages (1)

62559-417-01 100 TABLET in 1 BOTTLE (62559-417-01)

Ingredients (2)

benazepril hydrochloride (20 mg/1) hydrochlorothiazide (25 mg/1)

Linked Drug Pages (1)

Benazepril Hydrochloride and Hydrochlorothiazide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["ORAL"], "spl_id": "052493c7-89a3-452e-8140-04dd95f0d9e2", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776"], "upc": ["0362559415019", "0362559416016", "0362559414012", "0362559417013"], "unii": ["0J48LPH2TH", "N1SN99T69T"], "rxcui": ["898362", "898367", "898372", "898378"], "spl_set_id": ["e6527adf-8c74-4d81-9199-d56a7fca895e"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "manufacturer_name": ["ANI Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (62559-417-01)", "package_ndc": "62559-417-01", "marketing_start_date": "20221107"}], "brand_name": "Benazepril Hydrochloride and Hydrochlorothiazide", "product_id": "62559-417_052493c7-89a3-452e-8140-04dd95f0d9e2", "dosage_form": "TABLET", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Decreased Blood Pressure [PE]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "62559-417", "generic_name": "Benazepril Hydrochloride and Hydrochlorothiazide", "labeler_name": "ANI Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Benazepril Hydrochloride and Hydrochlorothiazide", "active_ingredients": [{"name": "BENAZEPRIL HYDROCHLORIDE", "strength": "20 mg/1"}, {"name": "HYDROCHLOROTHIAZIDE", "strength": "25 mg/1"}], "application_number": "ANDA076342", "marketing_category": "ANDA", "marketing_start_date": "20221107", "listing_expiration_date": "20261231"}